Anti-diabetic compounds from Uvaria dulcis Dunal

Medicinal plants have long been a source of lead compounds for drug discovery. Among these, the Annonaceae family has gained recognition for its potential to yield novel compounds, particularly those that can be used in the development of drugs targeting chronic diseases like diabetes mellitus (DM)....

Full description

Bibliographic Details
Main Authors: Passakorn Teerapongpisan, Rachanida Praparatana, Benjaporn Noppradit, Surat Laphookhieo, Panupong Puttarak
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024029931
_version_ 1797259776387710976
author Passakorn Teerapongpisan
Rachanida Praparatana
Benjaporn Noppradit
Surat Laphookhieo
Panupong Puttarak
author_facet Passakorn Teerapongpisan
Rachanida Praparatana
Benjaporn Noppradit
Surat Laphookhieo
Panupong Puttarak
author_sort Passakorn Teerapongpisan
collection DOAJ
description Medicinal plants have long been a source of lead compounds for drug discovery. Among these, the Annonaceae family has gained recognition for its potential to yield novel compounds, particularly those that can be used in the development of drugs targeting chronic diseases like diabetes mellitus (DM). We employed various chromatographic methods to isolate bioactive compounds from the roots, leaves, and twigs of Uvaria dulcis Dunal. We used spectroscopic methods to determine the chemical structures of these compounds. We successfully identified twelve known compounds from various parts of U. dulcis: patchoulenon, polygochalcone, 2′3′-dihydroxy-4′,6′-dimethoxydihydrochalcone, 2′,3′-dihydroxy-4′,6′-dimethoxychalcone, chrysin, techochrysin, 8-hydroxy-5,7-dimethoxyflavanone, pinocembrin, 3-farnesylindole, onysilin, cinchonain la, and cinchonain lb. Interestingly, cinchonain la and cinchonain lb exhibited more potent anti-α-glucosidase activity than acarbose (standard drug), with IC50 values of 11.88 ± 1.41 μg/mL and 15.18 ± 1.19 μg/mL, respectively. Cinchonain la inhibited the DPP-IV enzyme, with IC50 value lower than the standard compound (diprotin A) at 81.78 ± 1.42 μg/mL. While 2′,3′-dihydroxy-4′,6′-dimethoxychalcone show more potent inhibitory effect than standard drug with IC50 value of 8.62 ± 1.19 μg/mL. Additionally, at a concentration of 10 μg/mL, cinchonain lb and 2′,3′-dihydroxy-4′,6′-dimethoxychalcone promoted glucose uptake in L6 myotubes cells to the same extent as 100 nM insulin. These findings suggest that cinchonain la, cinchonain lb, and 2′,3′-dihydroxy-4′,6′-dimethoxychalcone are the U. dulcis-derived bioactive compounds that hold promise as potential structures to use in the development of anti-diabetic drugs.
first_indexed 2024-03-07T16:52:55Z
format Article
id doaj.art-3d34d1a505db4693852d8aa9490e61e4
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-24T23:14:48Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-3d34d1a505db4693852d8aa9490e61e42024-03-17T07:56:54ZengElsevierHeliyon2405-84402024-03-01105e26962Anti-diabetic compounds from Uvaria dulcis DunalPassakorn Teerapongpisan0Rachanida Praparatana1Benjaporn Noppradit2Surat Laphookhieo3Panupong Puttarak4Center of Chemical Innovation for Sustainability (CIS) and School of Science, Mae Fah Luang University, Chiang Rai 57100, ThailandFaculty of Medical Technology, Prince of Songkla University, Hat-Yai, Songkhla 90112, ThailandDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 90112, ThailandCenter of Chemical Innovation for Sustainability (CIS) and School of Science, Mae Fah Luang University, Chiang Rai 57100, Thailand; Medicinal Plant Innovation Center of Mae Fah Luang University, Chiang Rai 57100, Thailand; Corresponding author. Center of Chemical Innovation for Sustainability (CIS) and School of Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 90112, Thailand; Phytomedicine and Pharmaceutical Biotechnology Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 90112, Thailand; Corresponding author. Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 90112, Thailand.Medicinal plants have long been a source of lead compounds for drug discovery. Among these, the Annonaceae family has gained recognition for its potential to yield novel compounds, particularly those that can be used in the development of drugs targeting chronic diseases like diabetes mellitus (DM). We employed various chromatographic methods to isolate bioactive compounds from the roots, leaves, and twigs of Uvaria dulcis Dunal. We used spectroscopic methods to determine the chemical structures of these compounds. We successfully identified twelve known compounds from various parts of U. dulcis: patchoulenon, polygochalcone, 2′3′-dihydroxy-4′,6′-dimethoxydihydrochalcone, 2′,3′-dihydroxy-4′,6′-dimethoxychalcone, chrysin, techochrysin, 8-hydroxy-5,7-dimethoxyflavanone, pinocembrin, 3-farnesylindole, onysilin, cinchonain la, and cinchonain lb. Interestingly, cinchonain la and cinchonain lb exhibited more potent anti-α-glucosidase activity than acarbose (standard drug), with IC50 values of 11.88 ± 1.41 μg/mL and 15.18 ± 1.19 μg/mL, respectively. Cinchonain la inhibited the DPP-IV enzyme, with IC50 value lower than the standard compound (diprotin A) at 81.78 ± 1.42 μg/mL. While 2′,3′-dihydroxy-4′,6′-dimethoxychalcone show more potent inhibitory effect than standard drug with IC50 value of 8.62 ± 1.19 μg/mL. Additionally, at a concentration of 10 μg/mL, cinchonain lb and 2′,3′-dihydroxy-4′,6′-dimethoxychalcone promoted glucose uptake in L6 myotubes cells to the same extent as 100 nM insulin. These findings suggest that cinchonain la, cinchonain lb, and 2′,3′-dihydroxy-4′,6′-dimethoxychalcone are the U. dulcis-derived bioactive compounds that hold promise as potential structures to use in the development of anti-diabetic drugs.http://www.sciencedirect.com/science/article/pii/S2405844024029931DiabetesUvaria dulcis Dunalα-GlucosidaseGlucose uptakeDipeptidyl peptidase-IV
spellingShingle Passakorn Teerapongpisan
Rachanida Praparatana
Benjaporn Noppradit
Surat Laphookhieo
Panupong Puttarak
Anti-diabetic compounds from Uvaria dulcis Dunal
Heliyon
Diabetes
Uvaria dulcis Dunal
α-Glucosidase
Glucose uptake
Dipeptidyl peptidase-IV
title Anti-diabetic compounds from Uvaria dulcis Dunal
title_full Anti-diabetic compounds from Uvaria dulcis Dunal
title_fullStr Anti-diabetic compounds from Uvaria dulcis Dunal
title_full_unstemmed Anti-diabetic compounds from Uvaria dulcis Dunal
title_short Anti-diabetic compounds from Uvaria dulcis Dunal
title_sort anti diabetic compounds from uvaria dulcis dunal
topic Diabetes
Uvaria dulcis Dunal
α-Glucosidase
Glucose uptake
Dipeptidyl peptidase-IV
url http://www.sciencedirect.com/science/article/pii/S2405844024029931
work_keys_str_mv AT passakornteerapongpisan antidiabeticcompoundsfromuvariadulcisdunal
AT rachanidapraparatana antidiabeticcompoundsfromuvariadulcisdunal
AT benjapornnoppradit antidiabeticcompoundsfromuvariadulcisdunal
AT suratlaphookhieo antidiabeticcompoundsfromuvariadulcisdunal
AT panupongputtarak antidiabeticcompoundsfromuvariadulcisdunal